Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Roles for SUMOylation in Cellular Plasticity. | Trends Cell Biol | 2018 | 30463679 | PubTator, text mining | PubMed |
| Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD. | Sci Rep | 2018 | 30459441 | PubTator, text mining | PubMed |
| Ginkgolic Acid Rescues Lens Epithelial Cells from Injury Caused by Redox Regulated-Aberrant Sumoylation Signaling by Reviving Prdx6 and Sp1 Expression and Activities. | Int J Mol Sci | 2018 | 30413111 | PubTator, text mining | PubMed |
| SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. | Nat Commun | 2018 | 30375383 | PubTator, text mining | PubMed |
| Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma. | PLoS One | 2018 | 30352093 | PubTator, text mining | PubMed |
| Importance of Promyelocytic Leukema Protein (PML) for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. | Front Microbiol | 2018 | 30349510 | PubTator, text mining | PubMed |
| EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription. | J Cell Biol | 2018 | 30348749 | PubTator, text mining | PubMed |
| Ethanol-Induced Behavioral Sensitization Alters the Synaptic Transcriptome and Exon Utilization in DBA/2J Mice. | Front Genet | 2018 | 30319688 | PubTator, text mining | PubMed |
| ATR/Chk1 signaling induces autophagy through sumoylated RhoB-mediated lysosomal translocation of TSC2 after DNA damage. | Nat Commun | 2018 | 30297842 | PubTator, text mining | PubMed |
| Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells. | Toxicol Appl Pharmacol | 2018 | 30292834 | PubTator, text mining | PubMed |
| Roles of Post-translational Modifications in Spinocerebellar Ataxias. | Front Cell Neurosci | 2018 | 30283301 | PubTator, text mining | PubMed |
| Overexpression of small ubiquitin‑like modifier 2 ameliorates high glucose‑induced reductions in cardiomyocyte proliferation via the transforming growth factor‑β/Smad pathway. | Mol Med Rep | 2018 | 30280191 | PubTator, text mining | PubMed |
| SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin. | Front Genet | 2018 | 30279700 | PubTator, text mining | PubMed |
| UBL3 modification influences protein sorting to small extracellular vesicles. | Nat Commun | 2018 | 30258067 | PubTator, text mining | PubMed |
| Post-translational Modification-Based Regulation of HIV Replication. | Front Microbiol | 2018 | 30254620 | PubTator, text mining | PubMed |
| mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs. | Oncotarget | 2018 | 30237852 | PubTator, text mining | PubMed |
| Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis. | PLoS Pathog | 2018 | 30235352 | PubTator, text mining | PubMed |
| MicroRNA-194-5p Levels Decrease during Deep Hypothermic Circulatory Arrest. | Sci Rep | 2018 | 30232383 | PubTator, text mining | PubMed |
| Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV. | Int J Oncol | 2018 | 30226577 | PubTator, text mining | PubMed |
| Sumoylation-deficient Prdx6 repairs aberrant Sumoylation-mediated Sp1 dysregulation-dependent Prdx6 repression and cell injury in aging and oxidative stress. | Aging (Albany NY) | 2018 | 30215601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=53